EKSO
Price
$0.89
Change
-$0.00 (-0.00%)
Updated
Nov 7 closing price
111 days until earnings call
ICLR
Price
$215.49
Change
+$0.48 (+0.22%)
Updated
Nov 8, 03:26 PM (EDT)
103 days until earnings call
Ad is loading...

EKSO vs ICLR

Header iconEKSO vs ICLR Comparison
Open Charts EKSO vs ICLRBanner chart's image
Ekso Bionics Holdings
Price$0.89
Change-$0.00 (-0.00%)
Volume$41.08K
CapitalizationN/A
ICON
Price$215.49
Change+$0.48 (+0.22%)
Volume$727
CapitalizationN/A
View a ticker or compare two or three
EKSO vs ICLR Comparison Chart
Loading...
EKSO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
EKSO vs. ICLR commentary
Nov 09, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EKSO is a Hold and ICLR is a Buy.

COMPARISON
Comparison
Nov 09, 2024
Stock price -- (EKSO: $0.89 vs. ICLR: $215.01)
Brand notoriety: EKSO and ICLR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: EKSO: 61% vs. ICLR: 269%
Market capitalization -- EKSO: $24.35M vs. ICLR: $27.35B
EKSO [@Medical Specialties] is valued at $24.35M. ICLR’s [@Medical Specialties] market capitalization is $27.35B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EKSO’s FA Score shows that 1 FA rating(s) are green whileICLR’s FA Score has 0 green FA rating(s).

  • EKSO’s FA Score: 1 green, 4 red.
  • ICLR’s FA Score: 0 green, 5 red.
According to our system of comparison, EKSO is a better buy in the long-term than ICLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EKSO’s TA Score shows that 4 TA indicator(s) are bullish while ICLR’s TA Score has 4 bullish TA indicator(s).

  • EKSO’s TA Score: 4 bullish, 6 bearish.
  • ICLR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ICLR is a better buy in the short-term than EKSO.

Price Growth

EKSO (@Medical Specialties) experienced а +4.01% price change this week, while ICLR (@Medical Specialties) price change was -3.20% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.61%. For the same industry, the average monthly price growth was +3.41%, and the average quarterly price growth was -0.22%.

Reported Earning Dates

EKSO is expected to report earnings on Feb 27, 2025.

ICLR is expected to report earnings on Feb 19, 2025.

Industries' Descriptions

@Medical Specialties (+2.61% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ICLR($27.4B) has a higher market cap than EKSO($24.3M). ICLR YTD gains are higher at: -24.044 vs. EKSO (-64.388). ICLR has higher annual earnings (EBITDA): 1.52B vs. EKSO (-13.2M). ICLR has more cash in the bank: 380M vs. EKSO (8.64M). EKSO has less debt than ICLR: EKSO (7.17M) vs ICLR (3.94B). ICLR has higher revenues than EKSO: ICLR (8.12B) vs EKSO (18.3M).
EKSOICLREKSO / ICLR
Capitalization24.3M27.4B0%
EBITDA-13.2M1.52B-1%
Gain YTD-64.388-24.044268%
P/E RatioN/A44.81-
Revenue18.3M8.12B0%
Total Cash8.64M380M2%
Total Debt7.17M3.94B0%
FUNDAMENTALS RATINGS
EKSO vs ICLR: Fundamental Ratings
EKSO
ICLR
OUTLOOK RATING
1..100
6251
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
68
Overvalued
PROFIT vs RISK RATING
1..100
10054
SMR RATING
1..100
9877
PRICE GROWTH RATING
1..100
8588
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EKSO's Valuation (33) in the Medical Specialties industry is somewhat better than the same rating for ICLR (68) in the Pharmaceuticals Other industry. This means that EKSO’s stock grew somewhat faster than ICLR’s over the last 12 months.

ICLR's Profit vs Risk Rating (54) in the Pharmaceuticals Other industry is somewhat better than the same rating for EKSO (100) in the Medical Specialties industry. This means that ICLR’s stock grew somewhat faster than EKSO’s over the last 12 months.

ICLR's SMR Rating (77) in the Pharmaceuticals Other industry is in the same range as EKSO (98) in the Medical Specialties industry. This means that ICLR’s stock grew similarly to EKSO’s over the last 12 months.

EKSO's Price Growth Rating (85) in the Medical Specialties industry is in the same range as ICLR (88) in the Pharmaceuticals Other industry. This means that EKSO’s stock grew similarly to ICLR’s over the last 12 months.

ICLR's P/E Growth Rating (93) in the Pharmaceuticals Other industry is in the same range as EKSO (100) in the Medical Specialties industry. This means that ICLR’s stock grew similarly to EKSO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
EKSOICLR
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
65%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
62%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 11 days ago
68%
Declines
ODDS (%)
Bearish Trend 9 days ago
87%
Bearish Trend 2 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
57%
View a ticker or compare two or three
Ad is loading...
EKSO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ICLR
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NURO3.830.22
+6.09%
NeuroMetrix
EM0.69N/A
+0.01%
Smart Share Global Limited
GBDC15.36-0.03
-0.19%
Golub Capital BDC
CAG28.31-0.59
-2.04%
Conagra Brands
OFLX55.24-1.29
-2.28%
Omega Flex

EKSO and

Correlation & Price change

A.I.dvisor tells us that EKSO and ATEC have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and ATEC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
-1.90%
ATEC - EKSO
25%
Poorly correlated
+6.09%
GENE - EKSO
25%
Poorly correlated
N/A
ICLR - EKSO
24%
Poorly correlated
-3.95%
MASS - EKSO
24%
Poorly correlated
-6.91%
MXCT - EKSO
24%
Poorly correlated
-10.82%
More

ICLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICLR has been loosely correlated with IQV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if ICLR jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICLR
1D Price
Change %
ICLR100%
-3.95%
IQV - ICLR
64%
Loosely correlated
-1.61%
RGEN - ICLR
62%
Loosely correlated
-1.40%
CRL - ICLR
43%
Loosely correlated
-1.83%
MEDP - ICLR
40%
Loosely correlated
-1.35%
BSX - ICLR
34%
Loosely correlated
+0.51%
More